Orthopedic manifestations in patients with muco­polysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey

• Published in: Orthopedic Reviews Vol. 2; no. 2; p. e16
• Main Authors: Link, Bianca, Louise Lapagesse de Camargo Pinto, Giugliani, Roberto, Wraith, James Edmond, Guffon, Nathalie, Eich, Elke, Beck, Michael
• Format: Journal Article
• Language: English
• Published: Pavia PAGEPress Publications 23-09-2010; Open Medical Publishing
• Subjects: bone, joint, mucopolysaccharidosis, orthopedic, spine; Enzymes; Nervous system; Range of motion
• ISSN: 2035-8164; 2035-8237; 2035-8164
• DOI: 10.4081/or.2010.e16

Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a rare, inherited disorder caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase. As a result of this deficiency, glycosaminoglycans accumulate in lysosomes in many tissues, leading to progressive multisystemic disease. The cardiopulmonary and neurological problems associated with MPS II have received considerable attention. Orthopedic manifestations are common but not as well characterized. This study aimed to characterize the prevalence and severity of orthopedic manifestations of MPS II and to determine the relationship of these signs and symptoms with cardiovascular, pulmonary and central nervous system involvement. Orthopedic manifestations of MPS II were studied using cross-sectional data from the Hunter Outcome Survey (HOS). The HOS is a global, physician-led, multicenter observational database that collects information on the natural history of MPS II and the long-term safety and effectiveness of enzyme replacement therapy. As of January 2009, the HOS contained baseline data on joint range of motion in 124 males with MPS II. In total, 79% of patients had skeletal manifestations (median onset, 3.5 years) and 25% had abnormal gait (median onset, 5.4 years). Joint range of motion was restricted for all joints assessed (elbow, shoulder, hip, knee and ankle). Extension was the most severely affected movement: the exception to this was the shoulder. Surgery for orthopedic problems was rare. The presence of orthopedic manifestations was associated with the presence of central nervous system and pulmonary involvement, but not so clearly with cardiovascular involvement. Orthopedic interventions should be considered on an individual-patient basis. Although some orthopedic manifestations associated with MPS II may be managed routinely, a good knowledge of other concurrent organ system involvement is essential. A multidisciplinary approach is required.